ArticleOncology research2026

Integrative Machine Learning and Experimental Validation Identify MYBL2 as a Prognostic Biomarker and Therapeutic Target in Hepatocellular Carcinoma.

Ya-Ling Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.